How Merck prepares Market Access teams for tougher payer negotiations
Merck's Global Market Access team built a digital payer twin with Retorio. Local teams practice with realistic, adjustable AI payers before the real conversation.
Industry: Pharma
Use case: Payer negotiation coaching for Market Access
Markets: Spain, Latin America
The challenge
- Payers negotiate differently than physicians: Physicians share a medical background and engage on product value. Payers usually come from procurement or finance, and their priority is cost savings.
- An environment that changes every day: Market access conditions and payer needs shift constantly, so preparation has to keep pace.
- Preparing local teams: Merck wanted to know whether AI could better prepare local Market Access colleagues for their upcoming negotiations. The idea came from AInstein, the AI coaching program Merck's Global Oncology team already runs with Retorio.
Solution with Retorio
- A digital payer twin: Users negotiate with a realistic AI payer before the real meeting.
- Adjustable payer types: The team switches payer profiles and behaviors, so users practice against the counterpart they will actually face.
- Regularly refreshed content: Scenarios are updated to mirror the current market access environment.
Impact
- More comfortable in the room: Market Access colleagues come back saying they feel more comfortable when they go to negotiate with their different payers.
- Insight into every negotiation: After two years of development, the platform shows how each negotiation went and what to improve next.
- From pilot to roll-out: Started in Spain, now launching in the LATAM market, with a new use case for a new product in planning.
In use with Merck
2 years
of continuous development with the Global Market Access team
Roll-out
LATAM
launching now, after the pilot in Spain
Payer types
Adjustable
payer profiles and behaviors, matched to each market
“Market Access people come back to me saying: You know, now I am feeling more comfortable when I go to negotiate with my different payers.”
Dr. Nikola Vesic | Director Strategic Planning, Global Value Demonstration, Market Access & Pricing (GVAP), Merck







